KD:NYSEKyndryl Holdings, Inc. Analysis
Data as of 2026-06-02 - not real-time
$12.89
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is currently trading below its short‑term moving average and well beneath its longer‑term averages, indicating a bearish price environment. Momentum indicators show a neutral RSI and a MACD histogram that has turned positive, suggesting a modest bullish impulse amid overall weakness. Volume has been trending lower, reinforcing the lack of buying pressure. Recent earnings released a flat revenue year‑over‑year and a non‑GAAP profit that fell well short of consensus, highlighting earnings disappointment. The company’s margins remain thin, with operating profitability barely above break‑even.
Valuation metrics reveal a price‑to‑earnings multiple that is dramatically lower than the industry average, and a discounted cash‑flow model points to a substantial upside potential. The balance sheet shows ample cash relative to debt, yet the debt‑to‑equity ratio is extremely high, underscoring leverage concerns. Market sentiment is in the “extreme greed” zone, but the stock’s high thirty‑day volatility and beta above the market suggest heightened risk. Given the combination of undervaluation, weak earnings momentum, and elevated risk, investors should approach the position cautiously.
Valuation metrics reveal a price‑to‑earnings multiple that is dramatically lower than the industry average, and a discounted cash‑flow model points to a substantial upside potential. The balance sheet shows ample cash relative to debt, yet the debt‑to‑equity ratio is extremely high, underscoring leverage concerns. Market sentiment is in the “extreme greed” zone, but the stock’s high thirty‑day volatility and beta above the market suggest heightened risk. Given the combination of undervaluation, weak earnings momentum, and elevated risk, investors should approach the position cautiously.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- recent earnings miss
- price below short‑term average
- decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- discounted cash‑flow upside
- low price‑to‑earnings relative to peers
- strong cash position despite leverage
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- strategic AI partnership and service diversification
- steady demand for IT infrastructure services
- persistent leverage and debt concerns
Key Metrics & Analysis
Financial Health
Revenue Growth-0.80%
Profit Margin1.31%
P/E Ratio15.2
ROE15.09%
ROA3.33%
Debt/Equity383.59
P/B Ratio2.4
Op. Cash Flow$948.0M
Free Cash Flow$2.8B
Industry P/E42.9
Technical Analysis
TrendBearish
RSI54.6
Support$10.88
Resistance$14.77
MA 20$12.25
MA 50$12.88
MA 200$21.93
MACDBullish
VolumeDecreasing
Fear & Greed Index92.77
Valuation
Fair Value$154.34
Target Price$14.10
Upside/Downside9.39%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.20
Volatility54.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.